Home >> Marketplace Directory >> Qiagen, Natera to develop genetic testing assays, 5/18

Qiagen, Natera to develop genetic testing assays, 5/18

image_pdfCreate PDF

 

May 2018—Qiagen and Natera will partner to develop cell-free DNA assays, including for prenatal screening, for use on the Qiagen GeneReader NGS System.

The new noninvasive prenatal testing assays will analyze noninvasive maternal blood samples. The tests are expected to selectively differentiate fetal placental DNA from the background of the mother’s DNA to test whether a baby is at higher risk for common genetic conditions. The sample-to-insight workflow will provide personalized risk reports for health care and genetic counseling. Natera’s Constellation software will be accessible for users of these and other assays in combination with the Qiagen Clinical Insights bioinformatics solution.

Qiagen, 800-426-8157

Natera, 844-778-4700

CAP TODAY
X